Tetrahydrobenzimidazole TMQ0153 targets OPA1 and restores drug sensitivity in AML via ROS-induced mitochondrial metabolic reprogramming
四氢苯并咪唑类药物TMQ0153靶向OPA1,通过ROS诱导的线粒体代谢重编程恢复AML的药物敏感性。
期刊:Journal of Experimental & Clinical Cancer Research
影响因子:11.4
doi:10.1186/s13046-025-03372-0
Su Jung Park ,Claudia Cerella ,Jin Mo Kang ,Jinyoung Byun ,David Kum ,Barbora Orlikova-Boyer ,Anne Lorant ,Michael Schnekenburger ,Ali Al-Mourabit ,Christo Christov ,Juyong Lee ,Byung Woo Han ,Marc Diederich